Richard Drake
Professor and Endowed Chair in Proteomics
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Richard Drake is a Professor and Endowed Chair in Proteomics at the Medical University of South Carolina, USA. His research focuses on the roles of glycosylation in cancer and neurodegenerative diseases, with recent publications addressing fucosylated N-glycans in triple-negative breast cancer and glycan changes in liver disease and Parkinson's disease. He is also exploring innovative proteomic techniques to identify extracellular matrix proteins and biomarker discovery in various cancers.
Articles (16)
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Parkinson's disease (PD) associated state of neuroinflammation due to the aggregation of aberrant proteins is widely reported. One type of post-translational modification involved in protein stability is glycosylation. Here, we aimed to characterize the human Parkinsonian nigro-striatal N-glycome, and related transcriptome/proteome, and its correlation with endoplasmic reticulum (ER) stress and unfolded protein response (UPR), providing a comprehensive characterization of the PD molecular signature. Significant changes were seen upon a PD: a 3% increase in sialylation and 5% increase in fucosylation in both regions, and a 2% increase in oligomannosylated N-glycans in the substantia nigra. In the latter, a decrease in the mRNA expression of sialidases and an upregulation in the UPR pathway were also seen. To show the correlation between these, we also describe a small in vitro study where changes in specific glycosylation trait enzymes (inhibition of sialyltransferases) led to impairments in cell mitochondrial activity, changes in glyco-profile, and upregulation in UPR pathways. This complete characterization of the human nigro-striatal N-glycome provides an insight into the glycomic profile of PD through a transversal approach while combining the other PD “omics” pieces, which can potentially assist in the development of glyco-focused therapeutics.
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Collaborators (13)
Wenjian Gan
Assistant Professor
Medical University of South Carolina
Abhay Pandit
University of Galway
Tiffany Penaloza
Medical University of South Carolina
Bethany Wolf
Associate Professor
Medical University of South Carolina
Martina Marchetti-Deschmann
TU Wien
Alexandra Naba
Associate Professor
University of Chicago
Yeonhee Park
Sungkyunkwan University
Lewis Roberts
Professor
Mayo Clinic College of Medicine and Science
Harikrishna Nakshatri
Professor
Indiana State University
Haizhen Wang
Medical University of South Carolina
Anand S. Mehta
Medical University of South Carolina
Amy Herr
Lloyd Distinguished Professor
University of California, Berkeley
Chen Chu
Dana-Farber Cancer Institute
Make your next move.
Prepare your application
Review drafts before you send them.